Fluorescent Human EP3 Receptor Antagonists.

Miriam Tomasch, J Stephan Schwed, Karina Kuczka, Sascha Meyer Dos Santos, Sebastian Harder, Rolf M Nüsing, Alexander Paulke, Holger Stark

文献索引：ACS Med. Chem. Lett. 3(9) , 774-9, (2012)

全文：HTML全文

摘要

Exchange of the lipophilc part of ortho-substituted cinnamic acid lead structures with different small molecule fluorophoric moieties via a dimethylene spacer resulted in hEP3R ligands with affinities in the nanomolar concentration range. Synthesized compounds emit fluorescence in the blue, green, and red range of light and have been tested concerning their potential as a pharmacological tool. hEP3Rs were visualized by confocal laser scanning microscopy on HT-29 cells, on murine kidney tissues, and on human brain tissues and functionally were characterized as antagonists on human platelets. Inhibition of PGE2 and collagen-induced platelet aggregation was measured after preincubation with novel hEP3R ligands. The pyryllium-labeled ligand 8 has been shown as one of the most promising structures, displaying a useful fluorescence and highly affine hEP3R antagonists.